These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9300578)

  • 21. Cellular effects of purvalanol A: a specific inhibitor of cyclin-dependent kinase activities.
    Villerbu N; Gaben AM; Redeuilh G; Mester J
    Int J Cancer; 2002 Feb; 97(6):761-9. PubMed ID: 11857351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell cycle arrest induced in human breast cancer cells by cyclin-dependent kinase inhibitors: a comparison of the effects exerted by roscovitine and olomoucine.
    Wesierska-Gadek J; Gueorguieva M; Wojciechowski J; Horky M
    Pol J Pharmacol; 2004; 56(5):635-41. PubMed ID: 15591654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CSF-1 activates MAPK-dependent and p53-independent pathways to induce growth arrest of hormone-dependent human breast cancer cells.
    Lee AW; Nambirajan S; Moffat JG
    Oncogene; 1999 Dec; 18(52):7477-94. PubMed ID: 10602507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of cyclin-dependent kinases by purine analogues.
    Veselý J; Havlicek L; Strnad M; Blow JJ; Donella-Deana A; Pinna L; Letham DS; Kato J; Detivaud L; Leclerc S
    Eur J Biochem; 1994 Sep; 224(2):771-86. PubMed ID: 7925396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tangeretin induces cell-cycle G1 arrest through inhibiting cyclin-dependent kinases 2 and 4 activities as well as elevating Cdk inhibitors p21 and p27 in human colorectal carcinoma cells.
    Pan MH; Chen WJ; Lin-Shiau SY; Ho CT; Lin JK
    Carcinogenesis; 2002 Oct; 23(10):1677-84. PubMed ID: 12376477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. G1-checkpoint function including a cyclin-dependent kinase 2 regulatory pathway as potential determinant of 7-hydroxystaurosporine (UCN-01)-induced apoptosis and G1-phase accumulation.
    Akiyama T; Sugiyama K; Shimizu M; Tamaoki T; Akinaga S
    Jpn J Cancer Res; 1999 Dec; 90(12):1364-72. PubMed ID: 10665655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53.
    Rao S; Lowe M; Herliczek TW; Keyomarsi K
    Oncogene; 1998 Nov; 17(18):2393-402. PubMed ID: 9811471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BMP-7-induced cell cycle arrest of anaplastic thyroid carcinoma cells via p21(CIP1) and p27(KIP1).
    Franzén A ; Heldin NE
    Biochem Biophys Res Commun; 2001 Jul; 285(3):773-81. PubMed ID: 11453659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells.
    Yin F; Giuliano AE; Law RE; Van Herle AJ
    Anticancer Res; 2001; 21(1A):413-20. PubMed ID: 11299771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of pRB, cyclin/cyclin-dependent kinases and E2F1/DP-1 in human tumor lines in cell culture and in xenograft tissues and response to cell cycle agents.
    Lu K; Shih C; Teicher BA
    Cancer Chemother Pharmacol; 2000; 46(4):293-304. PubMed ID: 11052627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of G1 phase arrest in MCF human breast cancer cells by pentagalloylglucose through the down-regulation of CDK4 and CDK2 activities and up-regulation of the CDK inhibitors p27(Kip) and p21(Cip).
    Chen WJ; Chang CY; Lin JK
    Biochem Pharmacol; 2003 Jun; 65(11):1777-85. PubMed ID: 12781329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate.
    Liang YC; Lin-Shiau SY; Chen CF; Lin JK
    J Cell Biochem; 1999 Oct; 75(1):1-12. PubMed ID: 10462699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. G1 phase accumulation induced by UCN-01 is associated with dephosphorylation of Rb and CDK2 proteins as well as induction of CDK inhibitor p21/Cip1/WAF1/Sdi1 in p53-mutated human epidermoid carcinoma A431 cells.
    Akiyama T; Yoshida T; Tsujita T; Shimizu M; Mizukami T; Okabe M; Akinaga S
    Cancer Res; 1997 Apr; 57(8):1495-501. PubMed ID: 9108451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 2,3,7,8-tetrachlorodibenzo-p-dioxin-dependent release from contact inhibition in WB-F344 cells: involvement of cyclin A.
    Dietrich C; Faust D; Budt S; Moskwa M; Kunz A; Bock KW; Oesch F
    Toxicol Appl Pharmacol; 2002 Sep; 183(2):117-26. PubMed ID: 12387751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CDK-inhibitor olomoucine inhibits cell death after exposure of cell lines to cytosine-arabinoside.
    Papazisis KT; Geromichalos GD; Kouretas D; Dimitriadis KA; Kortsaris AH
    Cancer Lett; 1999 Apr; 138(1-2):221-6. PubMed ID: 10378797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Flavopiridol, a cyclin-dependent kinase inhibitor, prevents spindle inhibitor-induced endoreduplication in human cancer cells.
    Motwani M; Li X; Schwartz GK
    Clin Cancer Res; 2000 Mar; 6(3):924-32. PubMed ID: 10741717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of cell-cycle effectors of proliferation in bladder tumor epithelial cells by the p75NTR tumor suppressor.
    Khwaja F; Djakiew D
    Mol Carcinog; 2003 Mar; 36(3):153-60. PubMed ID: 12619038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK) 2 and CDK4 in human breast carcinoma cells.
    Carlson BA; Dubay MM; Sausville EA; Brizuela L; Worland PJ
    Cancer Res; 1996 Jul; 56(13):2973-8. PubMed ID: 8674031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The radiosensitising effect of olomoucine derived synthetic cyclin-dependent kinase inhibitors.
    Korinkova G; Cwiertka K; Paprskarova M; Dzubak P; Hajduch M
    Neoplasma; 2010; 57(2):161-9. PubMed ID: 20099981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activin A induction of cell-cycle arrest involves modulation of cyclin D2 and p21CIP1/WAF1 in plasmacytic cells.
    Yamato K; Koseki T; Ohguchi M; Kizaki M; Ikeda Y; Nishihara T
    Mol Endocrinol; 1997 Jul; 11(8):1044-52. PubMed ID: 9212052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.